Skip to main content
Article thumbnail
Location of Repository

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study

By Inga-Lill Engvall, Björn Svensson, Birgitta Tengstrand, Kerstin Brismar and Ingiäld Hafström
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2656227
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1995). Altered relation between circulating levels of insulin-like growth factorbinding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
    2. (2003). Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis. Clin Chem Lab Med
    3. (1992). Avioli L: Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblastenriched cells.
    4. (1996). Bijlsma JW: Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis
    5. (1984). BL: Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum
    6. (1985). C: The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state. Arthritis Rheum
    7. (1991). CA: Bone mineral content in patients with rheumatoid arthritis: relationship to lowdose steroid therapy.
    8. (1994). Canalis E: Cellular and clinical perspectives on skeletal insulin-like growth factor I.
    9. (2005). CJ: Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: the Rancho Bernardo Study. Osteoporos Int
    10. (1991). Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGFII radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh)
    11. (2002). Does active treatment of rheumatoid arthritis limit disease-associated bone loss? Rheumatology (Oxford)
    12. (1996). Endert E: The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-1.
    13. (1994). Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis
    14. (2003). Foged NT, Delaisse JM: The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res
    15. (2006). Giustina A: Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab
    16. (2001). Guidelines on the use of biochemical markers of bone turnover in osteoporosis
    17. (2005). Hafstrom I: Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum
    18. (2007). Hafstrom I: Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
    19. (1994). Increased type I collagen degradation in early rheumatoid arthritis.
    20. (1993). Insulin-like growth factor (IGF) I and II and IGF binding protein
    21. (2003). Insulin-like growth factors (IGFs) and IGF-binding proteins in nephrotic syndrome children on glucocorticoid. Pharmacol Res
    22. (1993). JA: Risk of vertebral fracture in women with rheumatoid arthritis. BMJ
    23. (2001). KO: IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.
    24. (2008). KW: Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology. Cell Immunol
    25. (1993). Lemmens JA: Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med
    26. (2003). Lems WF: Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Arthritis Rheum
    27. (1997). Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases.
    28. (2003). LS: Low dose glucocorticoids in early rheumatoid arthritis. Clin Exp Rheumatol
    29. (1998). Lunar: Operator manual, Expert-XL software version 1.7. Lunar Corporation. Lunar Corporation
    30. (2003). Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol
    31. Metabolic Bone Disease. In Kelley's Textbook of Rheumatology Volume 2. 6th edition. Edited by: Ruddy S, Harris E, Sledge C.
    32. (2006). Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
    33. (2005). Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford)
    34. (2000). Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy. Rheumatology (Oxford)
    35. (2007). Report of the International Society for Clinical Densitometry
    36. (1987). revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum
    37. (2006). RH: AntiTNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. Ann Rheum Dis
    38. (1999). Riggs BL: Osteoporosis: gender differences and similarities. Lupus
    39. (1998). Rijn HJ, Bijlsma JW: Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers.
    40. (1988). Svensson B: Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol
    41. (1995). The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.
    42. (2002). The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int
    43. (2000). The use of biochemical markers of bone turnover in osteoporosis.
    44. (2008). Thomas T: Long term effects of Infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis
    45. (1994). Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up.
    46. (2002). Ulfgren AK: Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology (Oxford)
    47. (1996). Woolf AD: Bone mass measurement and bone metabolism in rheumatoid arthritis: a review.
    48. (1989). Yeates MG: Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.